BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22394039)

  • 1. Tumor markers panel and tumor size of ovarian dermoid tumors in reproductive age.
    Var T; Tonguc EA; Ugur M; Altinbas S; Tokmak A
    Bratisl Lek Listy; 2012; 113(2):95-8. PubMed ID: 22394039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of tumor marker in ovarian dermoid cyst].
    Mikuni M; Makinoda S; Tanaka T; Okuda T; Domon H; Fujimoto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):479-84. PubMed ID: 2373920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors.
    Nagata H; Takahashi K; Yamane Y; Yoshino K; Shibukawa T; Kitao M
    Gynecol Obstet Invest; 1989; 28(3):165-8. PubMed ID: 2680806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between tissue and serum content of CA 125, CA 19-9, and carcinoembryonic antigen in ovarian tumors.
    Breitenecker G; Neunteufel W; Bieglmayer C; Kölbl H; Schieder K
    Int J Gynecol Pathol; 1989; 8(2):97-102. PubMed ID: 2714933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor markers in mature cystic teratomas of the ovary.
    Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
    Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic management of dermoid cysts in patients of reproductive age.
    Kaminski P; Gajewska M; Wielgos M; Szymusik I
    Neuro Endocrinol Lett; 2006 Dec; 27(6):818-21. PubMed ID: 17187015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA 19-9 can be a useful tumor marker in ovarian dermoid cysts.
    Coskun A; Kiran G; Ozdemir O
    Clin Exp Obstet Gynecol; 2008; 35(2):137-9. PubMed ID: 18581770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol, gonadotropins, and tumor markers in ovarian cyst fluid.
    Reimer T; Gerber B; Kunkel S; Luettich K
    Acta Obstet Gynecol Scand; 1997 May; 76(5):478-83. PubMed ID: 9197453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
    Ayhan A; Guven S; Guven ES; Kucukali T
    Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum level of the tumor marker CA 125 in ovarian pathology].
    Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
    Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEA and CA 19-9 in benign pulmonary or mediastinal cystic lesions.
    Uyama T; Monden Y; Sumitomo M; Miura K; Kimura S
    J Surg Oncol; 1989 Jun; 41(2):103-8. PubMed ID: 2724976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor markers for ovarian cancers].
    Aoki D; Kataoka F; Susumu N; Nozawa S
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():496-502. PubMed ID: 15535295
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian damage due to cyst removal: a comparison of endometriomas and dermoid cysts.
    Perlman S; Kjer JJ
    Acta Obstet Gynecol Scand; 2016 Mar; 95(3):285-90. PubMed ID: 26669273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative Rupture of Ovarian Dermoid Cysts in the Pediatric and Adolescent Population: Should This Change Your Surgical Management?
    Childress KJ; Santos XM; Perez-Milicua G; Hakim J; Adeyemi-Fowode O; Bercaw-Pratt JL; Dietrich JE
    J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):636-640. PubMed ID: 28336475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic treatment of ovarian cysts in adolescents and young adults.
    Seckin B; Ozdener T; Tapisiz OL; Batioğlu S
    J Pediatr Adolesc Gynecol; 2011 Oct; 24(5):300-3. PubMed ID: 21715192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case report of ovarian squamous cell carcinoma developing into a dermoid cyst with malignant transformation--immunohistochemical study].
    Nakanishi Y; Nagai N; Shigemsa K; Myoga H; Egawa K; Tanaka T; Katsube Y; Nakagawa H; Fuziwara A
    Gan No Rinsho; 1987 Nov; 33(14):1860-5. PubMed ID: 2447309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.